Position in TLRY
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$175,666
+$49,933 QoQ
Shares Held
27,151
+95.0% QoQ
Ownership
0.023%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TLRY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Engineers Gate Manager LP holds $37,551,467 across 27 Drug Manufacturers - Specialty & Generic names. TLRY ranks #22 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ELAN |
Elanco Animal Health Inc
|
338,218 | $8,093,556 | |
| 2 | ALKS |
Alkermes plc.
|
208,497 | $7,372,453 | |
| 3 | VTRS |
Viatris Inc
|
167,699 | $2,265,613 | |
| 4 | LQDA |
Liquidia Corp
|
53,625 | $2,023,807 | |
| 5 | BCRX |
Biocryst Pharmaceuticals Inc
|
194,475 | $1,851,402 | |
| 6 | COLL |
Collegium Pharmaceutical, Inc
|
49,814 | $1,647,348 | |
| 7 | NBIX |
Neurocrine Biosciences Inc
|
11,198 | $1,475,224 | |
| 8 | PAHC |
Phibro Animal Health Corp
|
24,862 | $1,375,117 |
All Filings in TLRY
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $175,666 | 27,151 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $125,733 | 13,924 | Shares | Sole | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||